[PDF][PDF] A novel insight into the nature of modified low-density lipoproteins and their role in atherosclerosis

DA Kashirskikh, S Guo, S Panyod, NR Chicherina… - Vessel Plus, 2023 - researchgate.net
Atherosclerosis plays a significant role in the development of cardiovascular diseases, the
leading cause of death worldwide. Modification of low-density lipoproteins (LDLs) is a critical …

Modified and dysfunctional lipoproteins in atherosclerosis: Effectors or biomarkers?

AN Orekhov, IA Sobenin - Current Medicinal Chemistry, 2019 - ingentaconnect.com
Atherosclerotic diseases are the leading cause of mortality in industrialized countries.
Correspondingly, studying the pathogenesis of atherosclerosis and developing new …

We Must Abandon the Myth: Oxidized Low-density Lipoprotein is not a Lipoprotein that Plays a Key Role in Atherogenesis

AN Orekhov - Current Medicinal Chemistry, 2024 - ingentaconnect.com
The purpose of this review is to revisit in detail the arguments supporting or disproving the
hypothesis that oxidized low-density lipoprotein (LDL) plays a key role in atherosclerotic …

Initiation and progression of atherosclerosis–enzymatic or oxidative modification of low-density lipoprotein?

M Torzewski, KJ Lackner - Clinical Chemistry and Laboratory …, 2006 - degruyter.com
Atherosclerosis is widely regarded as a chronic inflammatory disease that develops as a
consequence of entrapment of low-density lipoprotein (LDL) in the arterial intima. Native …

[图书][B] Modified forms of LDL in plasma

JL Sánchez-Quesada, S Villegas - 2011 - books.google.com
High blood concentration of low-density lipoprotein (LDL) cholesterol is a major risk factor
for early development of atherosclerosis. Massive accumulation of cholesterol in the arterial …

Oxidation of low-density lipoprotein in atherosclerosis from basic biochemistry to clinical studies

R Albertini, R Moratti, G Luca - Current molecular medicine, 2002 - ingentaconnect.com
Although it has been known for long time that atherosclerosis is associated with lipid
deposition, only recently it has been accepted that the plasmatic concentration of …

The role of modified and dysfunctional lipoproteins in atherogenesis

AN Orekhov - Current Medicinal Chemistry, 2019 - ingentaconnect.com
As in the first reviews of this Special Issue [2, 3], the review by Pirillo and co-workers [8]
states that focus should be shifted from HDL-C levels toward HDL functional properties. The …

[PDF][PDF] Modified lipoproteins as biomarkers of atherosclerosis.

AN Orekhov, IA Sobenin - risk, 2018 - article.imrpress.com
Pathogenesis of atherosclerosis and the search for novel therapies and diagnostic markers
remain major problems of modern medicine. Currently available therapeutic approaches are …

Atherogenic modification of low-density lipoproteins

VN Sukhorukov, VP Karagodin… - Biomeditsinskaya …, 2016 - pbmc.ibmc.msk.ru
One of the first manifestations of atherosclerosis is accumulation of extra-and intracellular
cholesterol esters in the arterial intima. Formation of foam cells is considered as a trigger in …

Multiple-modified low-density lipoprotein as atherogenic factor of patients' blood: Development of therapeutic approaches to reduce blood atherogenicity

NG Nikifirov, ER Zakiev, NV Elizova… - Current …, 2017 - ingentaconnect.com
Generally, atherosclerosis first occurs by the way of accumulation of intracellular and
extracellular lipids in the arterial intima. Foam cells, overloaded by lipids, are the essential …